Pages that link to "Q24802857"

The following pages link to The diagnosis and management of pre-invasive breast disease Genetic alterations in pre-invasive lesions (Q24802857):

Displaying 44 items.

• The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ (Q24803386) (← links)
• The diagnosis and management of pre-invasive breast disease--current challenges, future hopes (Q24803624) (← links)
• The diagnosis and management of pre-invasive breast disease: another point of view (Q24803959) (← links)
• The diagnosis and management of pre-invasive breast disease: editor's reply (Q24803975) (← links)
• Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast (Q28083103) (← links)
• Atypical epithelial hyperplasia of the breast: state of the art. (Q30249199) (← links)
• Laser capture microdissection, microarrays and the precise definition of a cancer cell (Q31125432) (← links)
• Early loss of heterozygosity on chromosome arm 16q in flat epithelial atypia of the breast. Detection by microsatellite analyses (Q33370954) (← links)
• High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast (Q33515565) (← links)
• Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis (Q33533666) (← links)
• Breast cancer proteomics: a review for clinicians (Q33862872) (← links)
• A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma. (Q33997933) (← links)
• Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages (Q35153040) (← links)
• Classification of ductal carcinoma in situ by gene expression profiling (Q35605885) (← links)
• Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression (Q35636561) (← links)
• Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma (Q35846896) (← links)
• Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies (Q35940073) (← links)
• Intraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer? (Q35979090) (← links)
• Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study (Q36072188) (← links)
• Non-invasive proteomics-thinking about personalized breast cancer screening and treatment (Q36117711) (← links)
• Characterization of breast cancer by array comparative genomic hybridization. (Q36916665) (← links)
• Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression (Q37316573) (← links)
• High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision (Q37339916) (← links)
• Preinvasive breast cancer (Q37569919) (← links)
• MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1. (Q37744880) (← links)
• Molecular biology of breast tumor progression: a view from the other side (Q37756399) (← links)
• A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancer. (Q37929842) (← links)
• Ductal carcinoma in situ - update on risk assessment and management (Q38696796) (← links)
• Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens (Q38845987) (← links)
• Genome evolution in ductal carcinoma in situ: invasion of the clones (Q39012815) (← links)
• P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. (Q42504546) (← links)
• Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression (Q44792714) (← links)
• Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. (Q53272132) (← links)
• Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. (Q54399355) (← links)
• Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. (Q54448978) (← links)
• miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a. (Q55381402) (← links)
• Breast cancer (Q56994859) (← links)
• Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence (Q57159647) (← links)
• Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer (Q61896370) (← links)
• Breast cancer precursors: lessons learned from molecular genetics (Q61970355) (← links)
• Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast. (Q64941348) (← links)
• In patients with DCIS: is it sufficient to histologically examine only those tissue specimens that contain microcalcifications? (Q80467586) (← links)
• [Flat epithelial atypia] (Q83229569) (← links)
• Downregulation of miR-505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer (Q91755923) (← links)